Neurosoft Company informs you that since March 25, 2021 Neuroline, SL is no longer the...

It’s more than a year since the COVID-19 pandemic has started. During this time, both the virus and scientific...

We continue to bring you the news on the results of Protecting Brains & Saving Futures project. It started...

Most people infected with the COVID-19 virus experience mild to moderate respiratory illness and recover without...

Recently, an advanced training course for doctors in the diagnosis of human brain death was held at Nanfang Hospital...

One of the prominent Russian authors Ivan Turgenev wrote: “Happiness has no tomorrow; it has no yesterday;...

The number of patients requiring rehabilitation after COVID-19 has been increasing lately. In August, Neurosoft...

Dear friends! We have great news! Now our “Neuron-Spectrum-65/PSG” and...

In our daily life, we are using artificial intelligence more and more often. Voice assistants in phones, automatic...

Various diagnostic activities are essential for treatment and follow-up of patients with COVID-19. According...

The number of patients affected by COVID-19 and requiring rehabilitation after a long-term treatment is growing day...

COVID-19 patients with cardiovascular disease or who are at high cardiovascular risk are the most...